Advances in the diagnosis and treatment of fungal infections of the CNS

S Schwartz, DP Kontoyiannis, T Harrison… - The Lancet …, 2018 - thelancet.com
Fungal infections of the CNS are challenging to treat and their optimal management requires
knowledge of their epidemiology, host characteristics, diagnostic criteria, and therapeutic …

[HTML][HTML] Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

AK Johnson, Z Ghazarian, KD Cendrowski… - Medical mycology case …, 2021 - Elsevier
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal
infections. Most documented cases have been reported in patients with diabetes mellitus …

Aspergillus peritonitis in peritoneal dialysis patients: a systematic review

J Dotis, A Kondou, E Koukloumperi, V Karava… - Journal de Mycologie …, 2020 - Elsevier
Fungal peritonitis in patients undergoing peritoneal dialysis (PD) is very difficult to treat and
is associated with significant morbidity and mortality. Among fungal pathogens, Aspergillus …

[HTML][HTML] Aspergillus fumigatus

MV Bandres, P Modi, S Sharma - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the pathophysiology of aspergillus infection. Explain the work up of a
patient with aspergillus. Outline the treatment and management options available for …

Performance of rapid on-site evaluation of touch imprints of bronchoscopic biopsies or lung tissue biopsies for the diagnosis of invasive pulmonary filamentous fungi …

H Wang, D Yu, X Chen, Y Zhou, X Qian… - Journal of Clinical …, 2024 - Am Soc Microbiol
The diagnosis of invasive pulmonary fungal disease depends on histopathology and
mycological culture; there are few studies on touch imprints of bronchoscopic biopsies or …

Invasive aspergillosis in the patient with focal segmental glomerulosclerosis initiating hemodialysis: a case report and mini-review

N Sato, H Yokoi, M Ichioka, A Ishii, T Matsubara… - Renal Replacement …, 2022 - Springer
Background Invasive aspergillosis (IA) is a severe form of fungal infection caused by the
genus Aspergillus in immunocompromised hosts and has a high mortality rate. End-stage …

Clinical and epidemiological profile of patients with invasive aspergillosis from a fourth level hospital in Bogota, Colombia: a retrospective study

A Goyeneche-García, J Rodríguez-Oyuela, G Sánchez… - Journal of Fungi, 2021 - mdpi.com
Invasive aspergillosis (IA) is a severe mycosis caused by Aspergillus species. The infection
mainly affects immunocompromised patients with a significant clinical burden. This study …

Tocilizumab and Corticosteroids Increase Risk of COVID-19–Associated Pulmonary Aspergillosis Development Among Critically Ill Patients

MT Awad, RM Niwinski, A Beran… - American Journal of …, 2023 - journals.lww.com
METHODS We performed a systematic review and meta-analysis based on the Preferred
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA). 9 We performed a …

Two entities in pulmonary nodules of a diabetic patient receiving corticosteroid therapy for bullous pemphigoid: an autopsy case report

R Mizushima, K Haruhara, N Fukasawa, M Satake… - Bmc Infectious …, 2022 - Springer
Background Invasive pulmonary aspergillosis (IPA) is a serious complication occurring in
immunocompromised patients, who often show multiple nodular lesions with or without …

[HTML][HTML] Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis

JG Persichino, AD Can, TT Van, MN Matthews… - Medical mycology case …, 2018 - Elsevier
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal
infections. Most documented cases have been reported in non-cirrhotic patients with …